Abstract
To determine the causative organisms, antimicrobial susceptibility, and outcome of community- and hospital-acquired pneumonia in diabetics and to compare this with non-diabetics, sputum cultures done at King Abdulaziz University Hospital in the period between January 1998 and December 1999 were reviewed. A total of 354 cases were studied, of which 125 (35%) were diabetics. Diabetic patients were older with a male predominance compared to non-diabetics. H. influenza was the commonest pathogen in community-acquired pneumonia (CAP) in both diabetics and non-diabetics, but there was a predominance of Staphylococcus aureus in diabetics compared to non-diabetics. Gram-negative bacilli were the commonest pathogens in hospital-acquired pneumonia (HAP) in both diabetics and non-diabetics. Ampicillin, co-amoxyclav, flouroquinolones, second-generation cephalosporins and erythromycin were used empirically in CAP while aminoglycosides, fluoroquinolones and imipenem were used in HAP in both diabetics and non-diabetics. No significant difference in mortality was found between diabetics and non-diabetics, for either CAP or HAP
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 15 October 2000 / Accepted in revised form: 25 May 2001
Rights and permissions
About this article
Cite this article
Akbar, D. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol 38, 77–82 (2001). https://doi.org/10.1007/s005920170017
Issue Date:
DOI: https://doi.org/10.1007/s005920170017